KF
ACER

Krilogy Financial’s Acer Therapeutics Inc ACER Stock Holding History

Krilogy Financial’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-6
Closed -$1K – 618
2015
Q3 		$1K Buy
+6
New +$212 ﹤0.01% 597

Other funds holding ACER

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Krilogy Financial's ACER Position: Q4 2015 in Review

Krilogy Financial sold out of Acer Therapeutics Inc (ACER) in Q4 2015, closing a stake of 6 shares — an estimated $1K sold.

Krilogy Financial first reported a position in ACER in Q3 2015 and held it in 1 quarter. The position peaked at $1K in Q3 2015. 15 funds tracked by Wall St. Rank hold ACER as of Q4 2015.

  • Krilogy Financial reported no remaining Acer Therapeutics Inc position as of Q4 2015 after selling out during the quarter.
  • Krilogy Financial sold 6 Acer Therapeutics Inc shares in Q4 2015, an estimated $1K.
  • Krilogy Financial first reported a position in Acer Therapeutics Inc in Q3 2015 and held it in 1 quarter.
  • Krilogy Financial's Acer Therapeutics Inc position peaked at $1K in Q3 2015.
  • 15 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2015.

Based on Krilogy Financial's 13F filing for Q4 2015, filed 29 Feb 2016.